Influenza: from zoonosis to pandemic

Probable epidemic influenza outbreaks have been described as early as the 5th century BC, as part of the Cough of Perinthus associated with the winter solstice, in Hippocrates' Corpus Hippocraticum “Of the Epidemics” [1]. The word “influenza” was first introduced in the 16th century, defining the illness of the cold season that in the early 1930s was shown to be caused by “filterable agents”, since then called influenza viruses. Three types or genera of influenza viruses have been recognised (influenza A, B and C viruses), while a fourth genus has been recently proposed [2]. Today, we distinguish three manifestations of influenza in humans, which may impose from mild to severe morbidity and mortality burdens: zoonotic, pandemic and seasonal influenza, all caused by an infection with an influenza virus. Although our arsenal of intervention strategies for influenza has advanced in the past decades and a growing public conception has arisen of influenza as a usually seasonal inconvenience, threats posed by influenza A viruses, with their different manifestations and associated complications, are continuously knocking on our door. Global surveillance and advances in vaccine technology are essential to answer the threat of influenza pandemics http://ow.ly/Yt3e4

[1]  Harish Nair,et al.  Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis , 2011, The Lancet.

[2]  Colin A. Russell,et al.  The Global Circulation of Seasonal Influenza A (H3N2) Viruses , 2008, Science.

[3]  L. Reperant,et al.  Adaptive pathways of zoonotic influenza viruses: from exposure to establishment in humans. , 2012, Vaccine.

[4]  Martin Linster,et al.  Identification, Characterization, and Natural Selection of Mutations Driving Airborne Transmission of A/H5N1 Virus , 2014, Cell.

[5]  D. Pérez,et al.  Airborne Transmission of Highly Pathogenic H7N1 Influenza Virus in Ferrets , 2014, Journal of Virology.

[6]  Trevor Bedford,et al.  Global circulation patterns of seasonal influenza viruses vary with antigenic drift , 2015, Nature.

[7]  A. Lapedes,et al.  Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.

[8]  Z. Sheng,et al.  Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family , 2014, mBio.

[9]  D. Carnall Randomised controlled trials , 1999, BMJ.

[10]  A. Osterhaus,et al.  Prolonged Influenza Virus Shedding and Emergence of Antiviral Resistance in Immunocompromised Patients and Ferrets , 2013, PLoS pathogens.

[11]  E. Hartmann,et al.  Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus , 2011, Nature communications.

[12]  A. Osterhaus,et al.  Towards universal influenza vaccines? , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.

[13]  David E. Swayne,et al.  A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission , 2007, Science.

[14]  C. A. Russell,et al.  Antibody landscapes after influenza virus infection or vaccination , 2014, Science.

[15]  B. Grenfell,et al.  The immune response and within-host emergence of pandemic influenza virus , 2014, The Lancet.

[16]  Timothy B. Stockwell,et al.  The soft palate is an important site of adaptation for transmissible influenza viruses , 2015, Nature.

[17]  J. Taubenberger,et al.  Influenza : the Mother of All Pandemics , 2022 .

[18]  S. Toovey Influenza-associated central nervous system dysfunction: a literature review. , 2008, Travel medicine and infectious disease.

[19]  A. Monto,et al.  Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. , 2013, Vaccine.

[20]  S. Pocock,et al.  Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials , 2015, The Lancet.

[21]  J. Taubenberger,et al.  1918 Influenza: the Mother of All Pandemics , 2006, Emerging infectious diseases.

[22]  Theo M Bestebroer,et al.  Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets , 2012, Science.

[23]  B. Grenfell,et al.  Quantifying the risk of pandemic influenza virus evolution by mutation and re-assortment. , 2015, Vaccine.

[24]  Kathy Hancock Influenza A Virus , 2020, Definitions.

[25]  A. Osterhaus,et al.  Age distribution of cases caused by different influenza viruses , 2013, The Lancet Infectious Diseases.

[26]  C. Boucher,et al.  Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. , 2010, The New England journal of medicine.

[27]  J. Chan,et al.  The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities , 2013, The Lancet Infectious Diseases.

[28]  U. Siebert,et al.  Avian Influenza A(H10N7) Virus–Associated Mass Deaths among Harbor Seals , 2015, Emerging infectious diseases.

[29]  D. Burke,et al.  Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution , 2013, Science.

[30]  David L Smith,et al.  The Potential for Respiratory Droplet–Transmissible A/H5N1 Influenza Virus to Evolve in a Mammalian Host , 2012, Science.

[31]  C W Potter,et al.  A history of influenza , 2001, Journal of applied microbiology.

[32]  R. Krug,et al.  The Influenza Viruses , 2011, The Viruses.

[33]  T. Uyeki,et al.  Neuraminidase Inhibitors for Critically Ill Children With Influenza , 2013, Pediatrics.

[34]  Gabriele Neumann,et al.  Experimental adaptation of an influenza H5 haemagglutinin (HA) confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets , 2012, Nature.

[35]  L. Reperant,et al.  Advances in influenza vaccination , 2014, F1000prime reports.

[36]  T. Heikkinen,et al.  Seasonal influenza: the burden of disease in children. , 2011, Vaccine.